Search

Your search keyword '"Binfeng, Lu"' showing total 28 results

Search Constraints

Start Over You searched for: Author "Binfeng, Lu" Remove constraint Author: "Binfeng, Lu" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
28 results on '"Binfeng, Lu"'

Search Results

1. Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy

2. Price Forecasting of Marine Fish Based on Weight Allocation Intelligent Combinatorial Modelling

3. Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways

4. Dynamic formation characteristics and mechanism of hybrid laser arc welding surface layer by Ni-based filler metal based on rotating laser induction

5. Chronic Activation of LXRα Sensitizes Mice to Hepatocellular Carcinoma

6. Farnesylthiosalicylic acid-derivatized PEI-based nanocomplex for improved tumor vaccination

7. An individualized causal framework for learning intercellular communication networks that define microenvironments of individual tumors.

8. IL1R2 increases regulatory T cell population in the tumor microenvironment by enhancing MHC-II expression on cancer-associated fibroblasts

9. Autologous Cytokine-Induced Killer Cell Immunotherapy Enhances Chemotherapy Efficacy against Multidrug-Resistant Tuberculosis

10. The Half-Life-Extended IL21 can Be Combined With Multiple Checkpoint Inhibitors for Tumor Immunotherapy

13. Data from Tumor-Derived IL33 Promotes Tissue-Resident CD8+ T Cells and Is Required for Checkpoint Blockade Tumor Immunotherapy

14. Data from PD-1 Blockade Boosts Radiofrequency Ablation–Elicited Adaptive Immune Responses against Tumor

15. Tim-3+ Treg cells from HNSCC TIL secrete more cytokines. from Novel Effector Phenotype of Tim-3+ Regulatory T Cells Leads to Enhanced Suppressive Function in Head and Neck Cancer Patients

16. Treg viability, Ki-67 expression and Foxp3 expression were tested after being treated with IFN-γ for 48 hours from Novel Effector Phenotype of Tim-3+ Regulatory T Cells Leads to Enhanced Suppressive Function in Head and Neck Cancer Patients

17. Supplementary data from PD-1 Blockade Boosts Radiofrequency Ablation–Elicited Adaptive Immune Responses against Tumor

18. Data from Novel Effector Phenotype of Tim-3+ Regulatory T Cells Leads to Enhanced Suppressive Function in Head and Neck Cancer Patients

19. Genome-wide gain-of-function screening characterized lncRNA regulators for tumor immune response

21. Tumor suppressor p53 deficiency increases tumor immunogenicity through promoting IL33-mediated anti-tumor immune responses

22. Root Cause Analysis of Nonrelevant Indication of Magnetic Particle Test on 18MND5 Steel Welded Joints in the Steam Generator of a Nuclear Power Project

23. Targeting metabotropic glutamate receptor 4 for cancer immunotherapy

24. Mobilizing phospholipids on tumor plasma membrane implicates phosphatidylserine externalization blockade for cancer immunotherapy

25. Loss of Protein Kinase D2 Activity Protects Against Bleomycin-induced Dermal Fibrosis in Mice

26. IL1R2 increases regulatory T cell population in the tumor microenvironment by enhancing MHC-II expression on cancer-associated fibroblasts

27. Abstract 1326: Loss of p53 sensitizes tumor cells to immune checkpoint blockade therapy via upregulation of IL-33

28. Amphiregulin couples IL1RL1+ regulatory T cells and cancer-associated fibroblasts to impede antitumor immunity.

Catalog

Books, media, physical & digital resources